retatrutide clinical trial weight loss data VisualAbstract: reduces body by 17.5% in patients with obesity Lilly's triple agonist delivers up
Description
But for now, that promise remains largely unproven
The first RCT, focusing on exenatide, reported no significant reduction in alcohol consumption over 24 weeks
[DOI] [PMC free article] [PubMed] [Google Scholar] 78.Rubi B., Ljubicic S., Pournourmohammadi S., Carobbio S., Armanet M., Bartley C., Maechler P
These may not be suitable for individuals who are pregnant or have certain medical conditions
Doctors are debunking it
